Minimally-Invasive Achilles Suture Trial (MIAST): Non-Absorbable vs. Absorbable

Shrewsbury and Telford Hospital NHS Trust0 个研究点目标入组 64 人开始时间: 2021年8月9日最近更新: 2021年8月24日

试验速览

暂无简介。

•1. Mid-substance Achilles tendon rupture, diagnosed clinically by the presence of a palpable gap to the Achilles tendon, and increased Achilles Tendon Resting Angle and a calf squeeze test
•2. Age 18 - 65 years
•3. Active patients with Tegner =5 (Generally participates in sports on regular basis and is recreationally competitive
•4. Presenting <15 days following rupture
•5. Able to understand the spoken and written English language
•6. After consultation wishes to have operative repair of the Achilles tendon rather than non-operative management.
•7. Available for 12 months follow up at SATH

•1. Distal Achilles tendon rupture, identified by palpation of the distal stump ending <2cm proximal to the Achilles insertion
•2. Musculotendinous Achilles tendon ruptures
•3. Patients with Diabetes Mellitus, chronic inflammatory conditions, and musculoskeletal conditions preventing a single heel-rise prior to rupture
•4. A previous ipsilateral or contralateral Achilles tendon rupture
•5. Patients >110 kg & BMI >30 kg/m² owing to obesity giving an increased risk of wound, cast and functional brace complications

发起方

Shrewsbury and Telford Hospital NHS Trust